Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03641105

Enrollment

100

Registered

2018-08-21

Start date

2014-01-01

Completion date

2019-03-01

Last updated

2018-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnosis, Glycolysis, Lung Cancer, Survival

Brief summary

Detect the contents of glucose metabolism molecules in the tumor and adjacent normal samples of about 100 patients with lung adenocarcinoma using mass spectroscopy. Analyze the correlation between the contents and the clinicopathological characteristics and survival.

Interventions

DIAGNOSTIC_TESTDiagnostic test

detect the contents of glucose metabolism molecules using mass spectrum

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Primary lung adenocarcinoma

Exclusion criteria

* Other tumor histories, received radiotherapy or chemotherapy before surgery, tumor or adjacent normal tissues can't be obtained, patient rejected.

Design outcomes

Primary

Measure	Time frame	Description
disease-free survival	1 month	disease-free survival

Secondary

Measure	Time frame	Description
overall survival	1 month	overall survival

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026